Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Belimumab in Remission of VASculitis (BREVAS)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )
ClinicalTrials.gov Identifier:
NCT01663623
First received: August 9, 2012
Last updated: July 14, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)